Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Nanosonics Limited ( (AU:NAN) ) just unveiled an announcement.
Nanosonics Limited has announced the application for quotation of 33,295 ordinary fully paid securities on the Australian Securities Exchange (ASX). These securities are issued under an employee incentive scheme and are not subject to transfer restrictions, indicating a strategic move to enhance employee engagement and potentially improve company performance.
The most recent analyst rating on (AU:NAN) stock is a Sell with a A$4.00 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the healthcare industry, specializing in infection prevention solutions. The company’s primary product is a device for high-level disinfection of ultrasound probes, focusing on improving patient safety and reducing healthcare-associated infections.
YTD Price Performance: 46.84%
Average Trading Volume: 1,030,403
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$1.34B
See more data about NAN stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue